Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Minoxidil and Propecia are the only FDA-approved hair growth drugs, but concerns about side effects lead people to explore herbal alternatives.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

Low-level laser therapy is safe and can increase hair growth for male and female pattern hair loss.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Photobiomodulation may help with hair growth and wound healing, but research is inconsistent and needs better quality studies.

Bidirectional barbed sutures are effective and can reduce surgery time, with a low infection rate and potential cost savings despite being more expensive.

The ARTAS robotic system for hair restoration is efficient with fewer cuts than manual methods, but it's limited to certain hair types and can still leave scars.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Finasteride has a higher risk of reproductive side effects than minoxidil.

The document warns against US clinics selling untested stem cell treatments without FDA approval.

Newer skin resurfacing lasers reduce damage and scarring, with some approved for safe use and minimal side effects.

Exosomes could improve skin and hair treatments, but more research and regulation are needed.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Topical minoxidil is effective and safe for treating hair loss.

FDA-cleared devices may help treat hair loss, but more research needed; consult dermatologist before use.

Most people using biotin don't see skin improvements, and it may affect lab tests, so doctors shouldn't suggest it without confirming a deficiency.

Synthetic hair fibers for hair restoration were controversial in 2009 due to health risks and lack of support from the International Society of Hair Restoration.

Laser hair transplantation can be effective but should be limited to small areas and requires more training to ensure safety and effectiveness.

FDA-approved low-level light/laser therapy devices can significantly increase hair density in people with pattern hair loss.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Stem cells could be a better treatment for hair loss by reactivating dormant hair follicles.

Synthetic hair implants can cause severe infections and are risky.